JP2001521533A - 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス - Google Patents
反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシスInfo
- Publication number
- JP2001521533A JP2001521533A JP54492198A JP54492198A JP2001521533A JP 2001521533 A JP2001521533 A JP 2001521533A JP 54492198 A JP54492198 A JP 54492198A JP 54492198 A JP54492198 A JP 54492198A JP 2001521533 A JP2001521533 A JP 2001521533A
- Authority
- JP
- Japan
- Prior art keywords
- reaction medium
- reaction
- carbon dioxide
- bifunctional
- substrates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title claims abstract description 67
- 239000000758 substrate Substances 0.000 title claims abstract description 45
- 229910002092 carbon dioxide Inorganic materials 0.000 title claims abstract description 33
- 239000012429 reaction media Substances 0.000 title claims abstract description 33
- 239000001569 carbon dioxide Substances 0.000 title claims abstract description 30
- 230000001588 bifunctional effect Effects 0.000 title claims abstract description 21
- 238000005865 alkene metathesis reaction Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 46
- 239000003054 catalyst Substances 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 238000005649 metathesis reaction Methods 0.000 claims abstract description 20
- 150000001336 alkenes Chemical class 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 229920000642 polymer Polymers 0.000 claims abstract description 13
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 9
- 125000000524 functional group Chemical group 0.000 claims abstract description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- -1 transition metal salts Chemical class 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 150000001345 alkine derivatives Chemical group 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000012018 catalyst precursor Substances 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 6
- 150000001412 amines Chemical group 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- 229930013356 epothilone Natural products 0.000 claims description 3
- 150000003883 epothilone derivatives Chemical class 0.000 claims description 3
- 150000005171 halobenzenes Chemical class 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 150000002736 metal compounds Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002841 Lewis acid Substances 0.000 claims description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 2
- 239000002168 alkylating agent Substances 0.000 claims description 2
- 229940100198 alkylating agent Drugs 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 2
- 150000002118 epoxides Chemical class 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 150000002466 imines Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 2
- 150000003018 phosphorus compounds Chemical class 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical class 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 150000003457 sulfones Chemical class 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- 230000007704 transition Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 claims 2
- GJJSUPSPZIZYPM-UHFFFAOYSA-N 1,4-dioxacyclohexadecane-5,16-dione Chemical compound O=C1CCCCCCCCCCC(=O)OCCO1 GJJSUPSPZIZYPM-UHFFFAOYSA-N 0.000 claims 1
- QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- ZKVZSBSZTMPBQR-UHFFFAOYSA-N Civetone Natural products O=C1CCCCCCCC=CCCCCCCC1 ZKVZSBSZTMPBQR-UHFFFAOYSA-N 0.000 claims 1
- QCJQWJKKTGJDCM-UHFFFAOYSA-N [P].[S] Chemical compound [P].[S] QCJQWJKKTGJDCM-UHFFFAOYSA-N 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 150000001717 carbocyclic compounds Chemical group 0.000 claims 1
- 229950005499 carbon tetrachloride Drugs 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- ZKVZSBSZTMPBQR-UPHRSURJSA-N civetone Chemical compound O=C1CCCCCCC\C=C/CCCCCCC1 ZKVZSBSZTMPBQR-UPHRSURJSA-N 0.000 claims 1
- 230000001143 conditioned effect Effects 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 1
- 229920001519 homopolymer Polymers 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 150000001282 organosilanes Chemical group 0.000 claims 1
- 150000003839 salts Chemical group 0.000 claims 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 150000003555 thioacetals Chemical class 0.000 claims 1
- 150000003624 transition metals Chemical class 0.000 claims 1
- 238000009826 distribution Methods 0.000 abstract description 3
- 125000001424 substituent group Chemical group 0.000 abstract description 2
- 125000002355 alkine group Chemical group 0.000 abstract 1
- 239000000047 product Substances 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 10
- 238000006116 polymerization reaction Methods 0.000 description 9
- 238000007363 ring formation reaction Methods 0.000 description 8
- 229910001220 stainless steel Inorganic materials 0.000 description 8
- 239000010935 stainless steel Substances 0.000 description 8
- 239000012300 argon atmosphere Substances 0.000 description 7
- LKWSEWKSHVNILA-UHFFFAOYSA-N 1,4-dioxacyclohexadec-10-ene-5,16-dione Chemical compound O=C1CCCCC=CCCCCC(=O)OCCO1 LKWSEWKSHVNILA-UHFFFAOYSA-N 0.000 description 6
- 150000001993 dienes Chemical class 0.000 description 6
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 5
- 238000006798 ring closing metathesis reaction Methods 0.000 description 5
- MTTKFVBUVGIIIF-GQCTYLIASA-N (11e)-1-oxacyclohexadec-11-en-2-one Chemical compound O=C1CCCCCCCC\C=C\CCCCO1 MTTKFVBUVGIIIF-GQCTYLIASA-N 0.000 description 4
- 101150065749 Churc1 gene Proteins 0.000 description 4
- 102100038239 Protein Churchill Human genes 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QYISAMZRTGSBSJ-UHFFFAOYSA-N 1-(4-bromophenyl)cyclopent-3-en-1-ol Chemical compound C=1C=C(Br)C=CC=1C1(O)CC=CC1 QYISAMZRTGSBSJ-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- UNYMIBRUQCUASP-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonyl-2,5-dihydropyrrole Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC=CC1 UNYMIBRUQCUASP-UHFFFAOYSA-N 0.000 description 1
- PPJYSSNKSXAVDB-UHFFFAOYSA-N 3,3',5,5'-tetraiodothyroacetic acid Chemical compound IC1=CC(CC(=O)O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 PPJYSSNKSXAVDB-UHFFFAOYSA-N 0.000 description 1
- 230000035495 ADMET Effects 0.000 description 1
- 238000010485 C−C bond formation reaction Methods 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000010535 acyclic diene metathesis reaction Methods 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000007152 ring opening metathesis polymerisation reaction Methods 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 150000003623 transition metal compounds Chemical class 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B37/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms
- C07B37/10—Cyclisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/607—Unsaturated compounds containing a keto groups being part of a ring of a seven-to twelve-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.反応媒体中において1以上の均一または不均一メタセシス触媒の存在下、 二官能性または多官能性基質の選択的オレフィンメタセシスによる環状生成物の 製法であって、基質が置換または非置換アルケンまたはアルキン部分の形をとる 2以上の官能基を含有し、反応媒体が圧縮二酸化炭素からなることを特徴とする 方法。 2.反応媒体中において均一または不均一メタセシス触媒の存在下、二官能性 または多官能性基質の選択的オレフィンメタセシスによる環状またはポリマー生 成物の製法であって、基質が置換または非置換アルケンまたはアルキン部分の形 をとる2以上の官能基を含有し、反応媒体が圧縮二酸化炭素からなり、生成物分 布が反応媒体の密度によって調整されていることを特徴とする方法。 3.反応媒体の密度がd=0.2−1.5g・cm-3の範囲内、好ましくはd =0.4−1.5g・cm-3の範囲内、特に好ましくはd=0.6−1.5g・ cm-3の範囲内にあるように、反応温度および全圧力が相互に調整される請求項 1または2記載の環状生成物の製法。 請求項3記載の方法。 5.生成物が8〜11の環サイズを有するカルボ−またはヘテロ環式化合物で ある請求項4記載の方法。 および相同化合物、Arova16および相同化合物、シベトンおよび相同化合 物、ムスコンおよび相同化合物、Exaltonおよび相同化合物、Musce nonおよび相同化合物、エポチロンおよび相同化合物である請求項4記載の方 法。 7.反応媒体の密度がd=0.2−1.5g・cm-3の範囲内、好ましくはd =0.2−0.65g・cm-3の範囲内にあるように、反応温度および全圧力が 相互に調整される請求項2記載のポリマー生成物の製法。 8.生成物がホモポリマー、コポリマーおよびブロックコポリマーを包含する 2以上の基質分子を互いに結合することにより形成されるポリマーである請求項 7記載の方法。 9.圧縮二酸化炭素によって不活性化しないメタセシス活性金属化合物が触媒 または触媒前駆物質として用いられる請求項1−8のいずれか記載の方法。 10.遷移金属カルベン、または反応条件下で金属カルベンを形成する遷移金 属化合物、またはアルキル化剤を伴う遷移金属塩が触媒または触媒前駆物質とし て用いられる請求項9記載の方法。 11. [式中、R1−R6は、独立して水素、C2−C20アルケニル、C2−C20アルキニ ル、C1−C20アルキル、アリール、C1−C20カルボキシレート、C1−C20ア ルコキシ、C2−C20アルケニルオキシ、C2−C20アルキニルオキシ、アリール オキシ、C2−C20アルコキシカルボニル、C1−C20アルキルチオ、C1−C20 アルキルスルホニルまたはC1−C20アルキルスルフィニルから選択される残基 であり;その各々がC1−C12アルキル、C1−C12ペルフルオロアルキル、ハロ ゲン、C1−C5アルコキシまたはアリールで置換されていてもよく;ここに、環 状化合物において、残基R1−R10は互いに結合でき; X1−X3は、独立して、特にF-、Cl-、Br-、I-、CN-、SCN-、R1 O-、R1R2N-、(R1−R5)−アリル-、(R1−R5)−シクロペンタジエニ ル-(ここに、残基R1−R5は前記と同意義である)から選択される任意に 定義されたアニオンリガンドであり; L1−L3は、独立して、特にCO、CO2、R1NCO、R1R2C=CR3R4、 R1C≡CR2、R1R2C=NR3、R1C≡N、R1OR2、R1SR2、NR1R2R3 、PR1R2R3、AsR1R2R3、SbR1R2R3から選択される中性リガンドで あり; m、nは0〜6の整数である] で示される一般型I−IXの化合物が触媒または触媒前駆物質として使用される 請求項10記載の方法。 12.L1−L2=PR1R2R3(ここに、R1−R3は前記と同意義であり、好 ましい残基R1−R3はアリールまたはアルキル、特に第2級アルキルまたはシク ロアルキル残基である)である一般型Iのカルベン錯体が触媒または触媒前駆物 質として用いられ;R1=アリールおよびR2−R4=C1−C20アルキルであり、 その各々がC1−C12アルキル、C1−C12ペルフルオロアルキル、アリール、ハ ロゲンで置換されていてもよい一般型IIのカルベン錯体もまた好ましい請求項 11記載の方法。 13.二官能性または多官能性基質がコンホメーション的に予め組織化されて いるかまたは完全にフレキシブルである請求項1−12のいずれか記載の方法。 14.二官能性または多官能性基質が反応に関係する官能基に加えてメタセシ ス反応に影響を及ぼさない多数のさらなる基またはヘテロ原子を含有する請求項 1−13のいずれか記載の方法。 15.基またはヘテロ原子が独立して、分枝または非分枝アルキル残基、芳香 族または非芳香族炭素環式環、カルボン酸、エステル、エーテル、エポキシド、 シリルエーテル、チオエーテル、チオアセタール、無水物、イミン、シリルエノ ールエーテル、アンモニウム塩、アミド、ニトリル、ペルフルオロアルキル基、 gem−ジアルキル基、アルキン、アルケン、ハロゲン、アルコール、ケトン、 アルデヒド、カルバメート、カルボネート、ウレタン、スルホネート、スルホン 、スルホンアミド、ニトロ基、オルガノシラン単位、金属中心、酸素−、窒素− 、硫黄−、リン−含有ヘテロ環から選択される請求項14記載の方法。 16.二官能性または多官能性基質が1以上の第1級、第2級または第3級塩 基性アミン単位を含有する請求項1−15のいずれか記載の方法。 17.反応媒体に混合物としてまたは連続的に供給して基質の混合物を反応さ せる請求項1−16のいずれか記載の方法。 18.基質が全体的にまたは部分的に支持形態である請求項1−17のいずれ か記載の方法。 19.統合された方法において生成物を圧縮二酸化炭素中の連続反応に付す請 求項1−18のいずれか記載の方法。 20.反応媒体が付加的に、独立して、水、リン化合物、アミン、ペルフルオ ロ化合物、ルイス酸化合物、金属アルコキシド、有機溶媒(特にジクロロメタン 、トリクロロメタン、テトラクロロメタン、1,2−ジクロロエタン、トリクロ ロエテン、ベンゼン、トルエン、キシレン、クメン、ヘキサン、シクロヘキサン 、ハロベンゼン、テトラヒドロフラン、tert−ブチルメチルエーテル、ジエ チルエーテル、ジメトキシエタン、ジメチルホルムアミド、アセト酢酸エチル、 アセトン、ジメチルカルボネート、アルコール)から選択される1以上の添加剤 を含有する請求項1−19のいずれか記載の方法。 21.生成物が圧縮二酸化炭素の特有の溶媒特性を用いて単離される請求項1 −20のいずれか記載の方法。 22.化学生成物の分離後に残存する金属含有残渣をオレフィンメタセシスの 触媒として再利用する請求項1−21のいずれか記載の方法。 23.使用した二酸化炭素を再利用する請求項1−22のいずれか記載の方法 。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19716231A DE19716231A1 (de) | 1997-04-18 | 1997-04-18 | Olefinmetathese in komprimiertem Kohlendioxid |
DE19716231.2 | 1997-05-16 | ||
DE1997120798 DE19720798A1 (de) | 1997-05-16 | 1997-05-16 | Selektive Olefinmetathese von bi- oder polyfunktionellen Substraten in komprimiertem Kohlendioxid als Reaktionsmedium |
DE19720798.7 | 1997-05-16 | ||
PCT/EP1998/001977 WO1998047891A1 (de) | 1997-04-18 | 1998-04-04 | Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001521533A true JP2001521533A (ja) | 2001-11-06 |
JP4065573B2 JP4065573B2 (ja) | 2008-03-26 |
Family
ID=26035875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54492198A Expired - Fee Related JP4065573B2 (ja) | 1997-04-18 | 1998-04-04 | 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス |
Country Status (7)
Country | Link |
---|---|
US (1) | US6348551B1 (ja) |
EP (1) | EP0975622B1 (ja) |
JP (1) | JP4065573B2 (ja) |
AT (1) | ATE225783T1 (ja) |
CA (1) | CA2286610C (ja) |
DE (1) | DE59805900D1 (ja) |
WO (1) | WO1998047891A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007217343A (ja) * | 2006-02-16 | 2007-08-30 | Chiba Univ | フェノール化合物の製造法 |
JP2008526925A (ja) * | 2005-01-17 | 2008-07-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 圧縮二酸化炭素中で連続的閉環メタセシスを行う方法 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59609305D1 (de) | 1995-11-17 | 2002-07-11 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Herstellung |
EP0941227B2 (de) | 1996-11-18 | 2009-10-14 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Epothilon d, dessen herstellung und dessen verwendung als cytostatisches mittel bzw. als pflanzenschutzmittel |
JP4579351B2 (ja) | 1996-12-03 | 2010-11-10 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロンの合成とその中間体及びその類似物並びにその使用 |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
US6320045B1 (en) | 1997-12-04 | 2001-11-20 | Bristol-Myers Squibb Company | Process for the reduction of oxiranyl epothilones to olefinic epothilones |
US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
AU767185B2 (en) * | 1998-03-23 | 2003-11-06 | President And Fellows Of Harvard College | Synthesis of compounds and libraries of compounds |
US6380395B1 (en) | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
US6498257B1 (en) | 1998-04-21 | 2002-12-24 | Bristol-Myers Squibb Company | 2,3-olefinic epothilone derivatives |
US6780620B1 (en) | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
HUP0200076A3 (en) | 1999-02-22 | 2003-01-28 | Bristol Myers Squibb Co | C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them |
US6291684B1 (en) | 1999-03-29 | 2001-09-18 | Bristol-Myers Squibb Company | Process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
US6518421B1 (en) | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
US6593115B2 (en) | 2000-03-24 | 2003-07-15 | Bristol-Myers Squibb Co. | Preparation of epothilone intermediates |
UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
WO2002062338A1 (en) | 2001-01-25 | 2002-08-15 | Bristol-Myers Squibb Company | Parenteral formulation containing epothilone analogs |
WO2002058699A1 (en) * | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
BRPI0206509B8 (pt) | 2001-01-25 | 2021-05-25 | R Pharm Us Operating Llc | processo para formular, para administração parenteral, um análogo de epotilona, preparação farmacêutica, processo para formar uma composição farmacêutica para administração parental, composição farmacêutica e uso de um análogo de epotilona na preparação de uma composição farmacêutica para o tratamento de câncer |
HUP0303175A2 (hu) | 2001-02-20 | 2003-12-29 | Bristol-Myers Squibb Co. | Epotilonszármazékok alkalmazása makacs tumorok kezelésére alkalmas gyógyszerkészítmény előállítására |
EP1368030A1 (en) | 2001-02-20 | 2003-12-10 | Bristol-Myers Squibb Company | Epothilone derivatives for the treatment of refractory tumors |
CA2440555A1 (en) | 2001-03-14 | 2002-09-19 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
US20030113740A1 (en) * | 2001-04-26 | 2003-06-19 | Mirkin Chad A. | Oligonucleotide-modified ROMP polymers and co-polymers |
EP1392664A4 (en) | 2001-06-01 | 2005-01-26 | Bristol Myers Squibb Co | EPOTHILONE DERIVATIVES |
ES2337134T3 (es) | 2002-03-12 | 2010-04-21 | Bristol-Myers Squibb Company | Derivados de c3-ciano-epotilona. |
WO2003077903A1 (en) | 2002-03-12 | 2003-09-25 | Bristol-Myers Squibb Company | C12-cyano epothilone derivatives |
TW200403994A (en) | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
TW200400191A (en) | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
WO2003105828A1 (en) | 2002-06-14 | 2003-12-24 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
MXPA05002113A (es) | 2002-08-23 | 2005-06-03 | Sloan Kettering Inst Cancer | Sintesis de epotilonas, intermediarios para ellas, analogos y usos de los mismos. |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
ES2439995T3 (es) | 2002-09-23 | 2014-01-27 | Bristol-Myers Squibb Company | Procedimientos de preparación, aislamiento y purificación de epotilona B |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0776184B2 (ja) | 1990-03-28 | 1995-08-16 | ヘキスト・アクチェンゲゼルシャフト | レニウムオキサイドの有機誘導体よりなるオレフィン性化合物のエテンノーリシス的メタセシスのための触媒およびこれらの触媒を使用するオレフィン性化合物のエテンノーリシス的メタセシスの方法 |
US5840820A (en) * | 1995-04-13 | 1998-11-24 | The University Of North Carolina At Chapel Hill | Olefin metathesis reactions in carbon dioxide medium |
US5936100A (en) | 1996-12-16 | 1999-08-10 | Studiengesellschaft Kohle Mbh | Synthesis of functionalized macrocycles by ring closing metathesis |
-
1998
- 1998-04-04 WO PCT/EP1998/001977 patent/WO1998047891A1/de active IP Right Grant
- 1998-04-04 CA CA002286610A patent/CA2286610C/en not_active Expired - Fee Related
- 1998-04-04 DE DE59805900T patent/DE59805900D1/de not_active Expired - Lifetime
- 1998-04-04 EP EP98922644A patent/EP0975622B1/de not_active Expired - Lifetime
- 1998-04-04 US US09/403,331 patent/US6348551B1/en not_active Expired - Lifetime
- 1998-04-04 JP JP54492198A patent/JP4065573B2/ja not_active Expired - Fee Related
- 1998-04-04 AT AT98922644T patent/ATE225783T1/de active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008526925A (ja) * | 2005-01-17 | 2008-07-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 圧縮二酸化炭素中で連続的閉環メタセシスを行う方法 |
JP2007217343A (ja) * | 2006-02-16 | 2007-08-30 | Chiba Univ | フェノール化合物の製造法 |
JP4576533B2 (ja) * | 2006-02-16 | 2010-11-10 | 国立大学法人 千葉大学 | フェノール化合物の製造法 |
Also Published As
Publication number | Publication date |
---|---|
EP0975622A1 (de) | 2000-02-02 |
CA2286610C (en) | 2007-03-13 |
WO1998047891A1 (de) | 1998-10-29 |
CA2286610A1 (en) | 1998-10-29 |
ATE225783T1 (de) | 2002-10-15 |
EP0975622B1 (de) | 2002-10-09 |
DE59805900D1 (de) | 2002-11-14 |
US6348551B1 (en) | 2002-02-19 |
JP4065573B2 (ja) | 2008-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001521533A (ja) | 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス | |
Gansäuer et al. | A Radical Tandem Reaction with Homolytic Cleavage of a Ti O Bond | |
Fürstner et al. | Olefin metathesis in compressed carbon dioxide | |
Molander et al. | Sequenced reactions with samarium (II) iodide. Tandem intramolecular nucleophilic acyl substitution/intramolecular Barbier cyclizations | |
Schmidt et al. | Tandem olefin metathesis/hydrogenation at ambient temperature: activation of ruthenium carbene complexes by addition of hydrides | |
CA2612596C (en) | Hydroformylation process | |
EP2861552A1 (de) | Verfahren zur herstellung makrocyclischer ketone | |
JPS6331450B2 (ja) | ||
KR20080056245A (ko) | 폴리이소부텐의 제조 방법 | |
JP2007506691A (ja) | 1,7−オクタジエンの製造方法及びその使用 | |
Mahrwald | Catalytic, Diastereoselective Aldol Reactions Using Titanium (IV) Halides | |
DE19716231A1 (de) | Olefinmetathese in komprimiertem Kohlendioxid | |
WO2004058680A1 (en) | Cyclohexane derivatives and methods for their preparation | |
JP2001500110A (ja) | オレフィンからのアルコール及び/又はアルデヒドの製造方法 | |
Bach et al. | Reversal of the facial diastereoselectivity in the Paternò-Büchi reaction of silyl enol ethers carrying a chiral substituent in α-position | |
Marciniec et al. | Synthesis and structural characterization of trans‐tactic vinylene–silylene (siloxylene) polymers | |
YOSHIMATSU et al. | Generation and Alkylation of α-Lithio-Se, O-heteroacetals, and Stereoselective Cyclization of Olefinic Se, O-Heteroacetals | |
Singh et al. | Investigations on photochemistry of o-allyloxy-/crotyloxyacetophenones: formation of unexpected intramolecular arene–olefin addition products on n–π∗ excitation of ketones | |
EP1489106B1 (en) | Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same | |
DE19720798A1 (de) | Selektive Olefinmetathese von bi- oder polyfunktionellen Substraten in komprimiertem Kohlendioxid als Reaktionsmedium | |
Hilt et al. | Synthesis of polycyclic polyfunctionalized carbocycles by a cobalt (I)‐initiated tandem diels–alder reaction sequence | |
JPH024210B2 (ja) | ||
CN114127039A (zh) | 间二烷基苯甲醛的制造方法 | |
US5583271A (en) | Method for continuously producing alkadienols | |
EP0807100A1 (en) | Tricyclocarboxylate, method for preparing the same and perfume comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A625 | Written request for application examination (by other person) |
Free format text: JAPANESE INTERMEDIATE CODE: A625 Effective date: 20050404 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060228 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070731 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070718 Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070720 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071030 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071218 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080107 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110111 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110111 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120111 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130111 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |